American Century Companies’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Buy
20,364
+6,991
+52% +$704K ﹤0.01% 2195
2026
Q1
$1.18M Sell
13,373
-97
-0.7% -$8.36K ﹤0.01% 2279
2025
Q4
$1.06M Buy
13,470
+735
+6% +$55.9K ﹤0.01% 2298
2025
Q3
$853K Sell
12,735
-696
-5% -$50.1K ﹤0.01% 2352
2025
Q2
$1.27M Buy
13,431
+194
+1% +$21.3K ﹤0.01% 2192
2025
Q1
$1.57M Buy
13,237
+3,793
+40% +$517K ﹤0.01% 2083
2024
Q4
$1.25M Buy
9,444
+4,698
+99% +$577K ﹤0.01% 2185
2024
Q3
$616K Buy
+4,746
New +$558K ﹤0.01% 2399

Other funds holding MLAB

American Century Companies's MLAB Position: Q2 2026 in Review

American Century Companies increased its Mesa Laboratories (MLAB) stake by 52% in Q2 2026, buying an estimated $704K and bringing the position to 20,364 shares worth $2.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

American Century Companies first reported a position in MLAB in Q3 2024 and has held it in 8 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • American Century Companies held 20,364 shares of Mesa Laboratories worth $2.03M as of Q2 2026.
  • American Century Companies bought 6,991 Mesa Laboratories shares in Q2 2026, an estimated $704K.
  • Mesa Laboratories made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2195 holding.
  • American Century Companies first reported a position in Mesa Laboratories in Q3 2024 and has held it in 8 quarters since.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.